Country Spotlight: Rwanda
Our Work in Rwanda
EGPAF/Rwanda’s HIV program was developed to respond to Rwanda’s development vision for its health programs, which is comprised of a strategic plan (Rwanda Vision 2020), the Economic Development and Poverty Reduction Strategy (EDPRS), and other health sector strategies. The program also is aligned with donor mandates and bilateral accords such as the partnership framework between the U.S. and Rwandan Governments that focuses on HIV/AIDS prevention; care and treatment; quality of care; health systems strengthening (HSS); and transitioning of financial and technical management capacity to local institutions.
EGPAF/Rwanda assists in implementing comprehensive, integrated HIV clinical services at the site and central levels, providing technical expertise to health institutions to build their capacity to maintain high-quality HIV services in their districts. These include:
- Prevention of Mother-to-Child Transmission of HIV (PMTCT)
- Voluntary Counseling and Testing (VCT)
- Provider Initiated Testing (PIT)
- Care and Treatment services
- Support for tuberculosis screening and testing
- Maternal Infant and Young Child Nutrition (MIYCN)
- Maternal and Child Health / Family Planning / Sexual and Gender-Based Violence / Water and Sanitation (all supplemented with funding from USAID)
EGPAF also ensures that districts and sites can efficiently manage and disburse funds they receive through sub-agreements.
Finally, EGPAF/Rwanda is committed to sustainable, locally-owned programs, and works closely with the MOH, districts, and health facilities to address priorities and build local staff capacity. To this end, EGPAF/Rwanda offers grants, mentorship, and training to districts, health facilities, and community members.
As of September 30, 2012, EGPAF-supported programs in Rwanda have:
- Provided more than 266,000 women in Rwanda with PMTCT services.
- Enrolled more than 32,000 patients into HIV care and support programs, including nearly 2,000 children under the age of 15.
- Started more than 14,000 individuals on antiretroviral treatments (ART) for HIV/AIDS, including more than 1,100 children under the age of 15.